March 31 (Reuters) - Medipharm Labs Corp LABS.TO :
* MEDIPHARM LABS REPORTS FOURTH QUARTER AND FULL YEAR 2022
RESULTS
* MEDIPHARM LABS CORP - IMPLEMENTED RESTRUCTURING PLAN THAT
MANAGEMENT EXPECTS COULD REDUCE CANADIAN NON-MANUFACTURING
HEADCOUNT BY APPROXIMATELY 30%
* MEDIPHARM LABS CORP - EXPECTS RESTRUCTURING PLAN TO
POTENTIALLY
REDUCING ANNUALIZED EXPENSES BY APPROXIMATELY $3M
* MEDIPHARM LABS CORP - AIMS TO REACH POSITIVE EBITDA AND
CASH
FLOW IN FIRST HALF OF 2024
* MEDIPHARM LABS CORP - AT END OF Q4 2022, CO HAD $24
MILLION IN
CASH ON ITS BALANCE SHEET
Source text for Eikon: ID:nCNW4cMRka
Further company coverage: LABS.TO
((Reuters.Briefs@thomsonreuters.com;))